Castle Rock-based AspenBio Pharma Inc. began trading on the NASDAQ stock market today. The bio-pharmaceutical company which develops diagnostics previously traded on the Over-the-Counter Bulletin Board.
The company is trading on the NASDAQ under the symbol “APPY.” Shares were down 5 cents at $5.89 in early morning trading. AspenBio Pharma has a market capitalization of approximately $165 million.
However, shares of the company rose 9 percent in the two after NASDAQ officially approved the company’s listing, said AspenBio Pharma CEO Richard Donnelly.
“We are very excited with the opportunity to be listed and begin trading on NASDAQ,” he said in a written statement. “It would appear that the marketplace agrees with our assessment.”



